All News

A team of researchers led by Memorial Sloan-Kettering Cancer Center Thursday published work describing how they used machine learning, a form of artificial intelligence (AI), to predict tumor type from targeted DNA sequence data to predict tissue of origin, in a finding that may have implications to improve diagnostic and clinical care.

Financial assistance provided to patients in California who require dialysis is being threatened amid a new state law; WHO to certify insulins to curb rising prices; CDC warns of rising drug-resistant superbug threat.

The EPA proposal to limit science used in rulemaking was discussed by panel members during a hearing held today by the House Committee on Science, Space, and Technology, with patient confidentiality serving as a major issue.

The fluid in e-cigarettes were associated with the near fatal respiratory failure of a teenage boy who was found to have an exaggerated immune response to one of its chemicals while vaping, according to a report published this week by doctors.

Regulators and lawmakers have expressed concern over possible privacy breaches as Google and Ascension collect healthcare data; Amarin’s Vascepa goes before an FDA committee this week; CMS Administrator Seema Verma defends Medicaid work requirements.

Greater rates of adherence and persistence seen among patients on a single-tablet regimen.

Secondary analyses of data from the landmark CREDENCE trial show that the protective renal benefits of the SGLT2 inhibitor canagliflozin are greatest among type 2 diabetes patients with lower kidney function.

Updated Carthadex trial results show improved responses at the 58-month mark and build on findings from other studies.

Researchers proposed new diagnostic criteria for chronic obstructive pulmonary disease (COPD) that seek to identify more patients in early stages of the disease, promote better care for patients, and stimulate research to slow and prevent COPD, in a paper published today in the journal Chronic Obstructive Pulmonary Diseases.

EPA's new draft of their science transparency rule expands limitations on the use of science for agency rulemaking; cannabis-based medicine approved by National Health Service in England and Wales; medical care for mental health is expanding among adolescents.

As healthcare companies, tech firms, and startups seek to use digital tools to help individuals manage their health, patients have growing concerns about how their data are used. During a panel discussion during the opening day of the FT Global Pharmaceutical and Biotechnology Conference 2019, held this week in London, United Kingdom, executives from across the pharmaceutical and digital health spaces discussed the critical importance of building relationships with patients as a means to not only reap high-quality data, but also improve patients’ outcomes and save healthcare systems money.

Hypertrophic cardiomyopathy is often an inherited condition and patients may not show symptoms, or those symptoms may be vague, such as fatigue or shortness of breath. The condition can cause varied levels of risk and can result in sudden cardiac death.

Kaiser Permanente chairman and chief executive officer Bernard J. Tyson dies at 60; vitamin E acetate is linked as a potential cause of vaping-related lung injuries; Medicare’s outpatient premium cost is rising.

The report emphasizes the need for maximizing the implementation and improving treatment and prevention tools to fight HIV because adherence challenges remain.

The age of psoriasis onset determines whether arthritis or psoriasis starts first in patients with psoriatic arthritis (PsA).

Perhaps not surprisingly, younger children had higher levels of parental support overall; the study also found that mothers provided more support than fathers.

An interim analysis of migraine drug erenumab showed that it continued to be safe and well-tolerated, with an adverse event profile consistent with those found in shorter-term placebo-controlled studies.

A recent study sought to identify an mRNA biomarker that predicts chemosensitivity across multiple solid tumor subtypes, given the significant heterogeneity in response among patients to chemotherapies.

For their study, the authors wanted to expand on previous research results that suggest outcomes are improved among patients with multiple myeloma treated at high-volume facilities.

Socially deprived patients were younger, more frequently women, active smokers, living alone, and belonged to lower socioprofessional categories when compared with the non-socially deprived group, but they still benefitted from home-based pulmonary rehabilitation.

Patients with diabetes who participated in a program of group medical visits (GMVs) and intensive weight management showed improvements in glycemic control, according to a study published in JAMA Internal Medicine.

The use of fluticasone-containing inhaled corticosteroids (ICS) was linked to increased risk of pneumonia in patients with COPD, according to study findings.

First Stop Health’s inaugural 2019 Health Benefits Cost Containment Report found that reining in benefits spending is a top priority for employers, but many lack the data necessary to make effective changes, according to results of a survey of human resources professionals.

HHS takes action against Gilead; a report on fears of seasonal workers in Montana; the latest CDC data on preventable deaths show differences between urban and rural areas.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

CDC recommends that young men who have sex with men have an HIV test every 6 months.

This week, the top managed care news included CMS started planning for life after the Oncology Care Model; a judge blocked a rule requiring immigrants to have health coverage; Election Day brought news for Medicaid work rules.

States can reduce Medicaid spending if the beneficiaries are also veterans, explains a veteran who started outreach in Washington state, which has since saved over $100 million since 2002.